This HTML5 document contains 120 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q51899847
rdf:type
wikibase:Item
schema:description
tieteellinen artikkeli 2007年学术文章 vitenskapelig artikkel научни чланак 2007年學術文章 artikulong pang-agham мақолаи илмӣ teaduslik artikkel artículo científico publicado en 2007 مقالة علمية نشرت في 29 أكتوبر 2007 scientific article published on 29 October 2007 2007年学术文章 επιστημονικό άρθρο bài báo khoa học article científic article scientific 2007年學術文章 գիտական հոդված հրատարակված 2007 թվականի հոկտեմբերի 29-ին videnskabelig artikel מאמר מדעי wissenschaftlicher Artikel vitskapeleg artikkel научна статия 2007年學術文章 2007 nî lūn-bûn наукова стаття, опублікована в жовтні 2007 2007年学术文章 artigo científico article scientifique artigo científico articol științific 2007年學術文章 vědecký článek wetenschappelijk artikel tudományos cikk artykuł naukowy ২৯ অক্টোবর ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vetenskaplig artikel 2007年の論文 naučni članak სამეცნიერო სტატია artikull shkencor scienca artikolo научная статья artículu científicu vedecký článok scientific article published on 29 October 2007 2007年学术文章 บทความทางวิทยาศาสตร์ 2007年学术文章 artigo científico artikel ilmiah 2007년 논문 2007年学术文章 bilimsel makale scientific article published on 29 October 2007 articolo scientifico 2007年學術文章 научни чланак
p:P577
wds:Q51899847-B41220E9-DF8A-4BF2-A91E-F9A26ED2EC90
wdt:P577
2007-10-29T00:00:00Z
p:P2093
wds:Q51899847-05CD16D5-2B03-4464-A04F-7B57472EAA43 wds:Q51899847-2919036C-8095-4F30-A344-72E455894838 wds:Q51899847-8A4D46C2-3E94-4723-90C3-3636D046D22D wds:Q51899847-F7ED7088-C47A-4F17-88C3-150910950374 wds:Q51899847-EDAADF42-47B9-42FE-81D5-78B922FBF2E9
wdt:P2093
Xavier Le Loët Thao Pham Société Française de Rhumatologie Club Rhumatismes et Inflammation Alain Cantagrel
rdfs:label
Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis. Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis.
skos:prefLabel
Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis. Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis.
schema:name
Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis. Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis.
p:P50
wds:Q51899847-86E2CF83-0330-4068-A5E3-880271743A78 wds:Q51899847-994E1542-40B1-48ED-BF01-1CF64C267750 wds:Q51899847-A04BC05E-585D-4314-97B0-377B08A50417 wds:Q51899847-B5C882DE-C7CB-4570-9C6A-B06D2B7CD4C2 wds:Q51899847-14945B36-9C4F-4696-A013-1B71922B07F1 wds:Q51899847-28F0BEAF-5528-4B70-99D1-4185E7D4A628 wds:Q51899847-30C3501E-1346-4BEA-A5D9-EB3027DDE3CE wds:Q51899847-44363B9F-B1DF-430B-A529-719EABCF83EA wds:Q51899847-6E0E3D1B-BEAE-4FD1-95C6-655F43E29F8F wds:Q51899847-E443B4FF-16A4-41C6-B2D6-7D6B6FB42A43 wds:Q51899847-0A9B2396-95D3-4250-B938-9405985A318D
wdt:P50
wd:Q92568008 wd:Q58884902 wd:Q37368509 wd:Q40584136 wd:Q90348320 wd:Q93104907 wd:Q92771497 wd:Q63136268 wd:Q100630583 wd:Q95981622 wd:Q63862702
p:P1476
wds:Q51899847-2BD4F4D5-01D8-442A-8181-0A80096A63B4
wdt:P1476
Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis.
p:P304
wds:Q51899847-63E3F6B0-19FE-4748-9CA9-A254FDD250BA
wdt:P304
627-637
p:P31
wds:Q51899847-B836FA10-8E6D-409F-ABB3-6EBCB3CA83B7
wdt:P31
wd:Q13442814
p:P921
wds:Q51899847-F542781C-A91C-4D26-A988-BDFC62353D36
wdt:P921
wd:Q187255
p:P698
wds:Q51899847-AB8B2E04-8E9C-4276-A6B6-D3926CE3CB56
wdtn:P698
n10:18037319
wdt:P698
18037319
p:P1433
wds:Q51899847-DC525E77-62B7-43E5-BC8C-3F6F085260EC
wdt:P1433
wd:Q15752403
p:P433
wds:Q51899847-EA8B0902-C7E2-4B4C-B8FC-827772B6E0EA
p:P478
wds:Q51899847-DCB2C5CF-789A-41E1-BB9E-F392E47FE246
wdt:P433
6
wdt:P478
74
p:P356
wds:Q51899847-75011031-C0A0-4BA9-9ECC-A823002725C9
wdtn:P356
n12:J.JBSPIN.2007.10.001
wdt:P356
10.1016/J.JBSPIN.2007.10.001